Alleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE-/-/tg-EC-DHFR mice, and by folic acid

By sjmartinez • April 6, 2025

Zhang Y, Youn JY, Huang K, Zhang Y, Cai H. Alleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE^-/-/tg-EC-DHFR mice, and by folic acid. Redox Biol. 2025 Feb 27;82:103570. doi: 10.1016/j.redox.2025.103570. Epub ahead of print. PMID: 40184644.

Atherosclerosis, Diabetes, Diabetic atherogenesis, Dihydrofolate reductase, DHFR, Endothelial nitric oxide synthase, eNOS, uncoupling, Endothelial-specific DHFR transgenic mice, tg-EC-DHFR, NADPH oxidase isoform 1, NOX1, NOX1 knockout mice, apoE(-/-)/NOX1(-/y), apoE null mice, apoE(−/−), apoE/NOX1 double knockout mice, apoE(-/-)/NOX1(-/y),

Tags: apoE null mice, apoE(-/-)/NOX1(-/y), apoE(−/−), apoE/NOX1 double knockout mice, Atherosclerosis, Cardiology/Epi, DHFR, diabetes, Diabetic atherogenesis, Dihydrofolate reductase, Endothelial nitric oxide synthase, Endothelial-specific DHFR transgenic mice, eNOS, NADPH oxidase isoform 1, NOX1, NOX1 knockout mice, Post Doc, Publications, tg-EC-DHFR, Uncoupling

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]

Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: results from the CheckMate 459 phase III trial

Neely J, Yao J, Kudo M, Finn RS, Sangro B, Melero I, El-Khoueiry AB, Yau T, Harding JJ, Rosmorduc O, Tschaika M, Novosiadly R, Cruz[...]

Deep learning-enabled screening of chronic kidney disease from echocardiography

Yuan V, Ieki H, Sandhu A, Nguyen LH, Cheng PP, Chang ST, Ambrosy AP, Kwan AC, Go AS, Cheng S, Ouyang D. Deep learning-enabled screening[...]